Skip to main content
OpenTrials

Clinical trial condition

Generalized Myasthenia Gravis

Explore clinical trials studying Generalized Myasthenia Gravis. Study availability and eligibility vary by location and protocol.

51 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

Generalized Myasthenia Gravis trial results

Enrolling by invitation

An Extension Study Evaluating 6-week Treatment Cycles of Rozanolixizumab in Pediatric Study Participants With Generalized Myasthenia Gravis

NCT06540144

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Mg0008 40290 Bologna, Italy
  • Mg0008 40144 Milan, Italy
  • Mg0008 40733 Naples, Italy
  • Mg0008 20340 Fuchu-shi, Japan
View Trial Details
Enrolling by invitation

An Open-label Extension Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis

NCT06435312

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Mg0015 40144 Milan, Italy
  • Mg0015 40774 Katowice, Poland
  • Mg0015 40218 Warsaw, Poland
  • Mg0015 20220 Seoul, South Korea
View Trial Details
Enrolling by invitation

Evaluating Long-term Safety of Efgartigimod Administered Intravenously and Efgartigimod PH20 Administered Subcutaneously in Children With Generalized Myasthenia Gravis

NCT05374590

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +12 more
Locations
  • Ann and Robert H Lurie Children's Hospital of Chicago - Main Hospital Chicago, Illinois, United States
  • Atrium Health Neurology Specialty Care Charlotte, North Carolina, United States
  • University of Virginia (UVA) Health - Developmental Pediatrics Clinic Charlottesville, Virginia, United States
  • Universitair Ziekenhuis Antwerpen Edegem, Belgium
View all 16 locations
View Trial Details
Active, not recruiting

Study to Assess Safety, Efficacy, and Cellular Kinetics of YTB323 in Generalized Myasthenia Gravis

NCT06704269

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Univ Cali Irvine ALS Neuromuscular Orange, California, United States
  • Wake Forest Univ School of Medicine Winston-Salem, North Carolina, United States
  • Thomas Jefferson University Philadelphia, Pennsylvania, United States
  • Houston Methodist Hospital Houston, Texas, United States
View Trial Details
Active, not recruiting

A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.

NCT06517758

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • Fullerton Neuro and Headache Ctr Fullerton, California, United States
  • California Pacific Medical Center Sacramento, California, United States
  • Augusta University Georgia Augusta, Georgia, United States
View all 116 locations
View Trial Details
Active, not recruiting

A Phase 3 Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Patients With Acetylcholine Receptor Binding Antibody Seronegative Generalized Myasthenia Gravis

NCT06298552

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +13 more
Locations
  • HonorHealth Neurology - Bob Bove Neuroscience Institute Scottsdale, Arizona, United States
  • Loma Linda University Health Fresno, California, United States
  • First Choice Neurology Boca Raton Boca Raton, Florida, United States
  • SFM Clinical Research LLC Boca Raton, Florida, United States
View all 91 locations
View Trial Details

Related conditions